| Phosphonamidate prodrugs of a butyrophilin ligand display plasma stability and potent Vγ9 Vδ2 T cell stimulation NA Lentini, BJ Foust, CHC Hsiao, AJ Wiemer, DF Wiemer Journal of medicinal chemistry 61 (19), 8658-8669, 2018 | 44 | 2018 |
| Mixed aryl phosphonate prodrugs of a butyrophilin ligand BJ Foust, MM Poe, NA Lentini, CHC Hsiao, AJ Wiemer, DF Wiemer ACS Medicinal Chemistry Letters 8 (9), 914-918, 2017 | 43 | 2017 |
| Synthesis and bioactivity of the alanyl phosphonamidate stereoisomers derived from a butyrophilin ligand NA Lentini, CHC Hsiao, GB Crull, AJ Wiemer, DF Wiemer ACS medicinal chemistry letters 10 (9), 1284-1289, 2019 | 15 | 2019 |
| Mechanism of bisphosphonate-related osteonecrosis of the jaw (BRONJ) revealed by targeted removal of legacy bisphosphonate from jawbone using competing inert hydroxymethylene … H Okawa, T Kondo, A Hokugo, P Cherian, JJ Campagna, NA Lentini, ... Elife 11, e76207, 2022 | 13 | 2022 |
| Efficiency of bis-amidate phosphonate prodrugs NA Lentini, X Huang, MA Schladetsch, CHC Hsiao, DF Wiemer, ... Bioorganic & medicinal chemistry letters 66, 128724, 2022 | 6 | 2022 |
| Synthesis and metabolism of BTN3A1 ligands: Studies on modifications of the allylic alcohol NA Lentini, CM Schroeder, NM Harmon, X Huang, MA Schladetsch, ... ACS medicinal chemistry letters 12 (1), 136-142, 2020 | 4 | 2020 |
| A luciferase lysis assay reveals in vivo malignant cell sensitization by phosphoantigen prodrugs J Li, NA Lentini, DF Wiemer, AJ Wiemer Biochemical pharmacology 170, 113668, 2019 | 4 | 2019 |
| O-Vinylphosphonylated salicylaldehydes as aldo-vinyl bifunctional building blocks for anti-3, 4-disubstituted phosphadihydrocoumarins Q Wang, D Kong, T Huang, M Wu Synthesis 51 (15), 2923-2935, 2019 | 4 | 2019 |
| New and more effective prodrugs against adenovirus, other DNA viruses and coronavirus: development of a versatile, targetable, and highly tunable promoiety platform for … CE McKenna, Y Bi, J Fan, NA Lentini, J Lyu, SB Riemann, J Yang, X Zhao, ... World Vaccine Congress West Coast, 2023 | | 2023 |
| USC-026 and USC-089a Suppress the Replication of SARS-CoV-2 in the Lungs of Syrian Hamsters and Mitigate Viral Pathogenesis More Effectively than Remdesivir NA Lentini, JM Overhulse, SB Riemann, BA Kashemirov, A Cline-Smith, ... 36th International Conference on Antiviral Research, 2023 | | 2023 |
| Novel Prodrugs as Inhibitors of SARS-Coronavirus-2 CE McKenna, JM Overhulse, NA Lentini, BA Kashemirov, AE Tollefson, ... 34th International Conference on Antiviral Research, 2021 | | 2021 |
| Diamidate Prodrugs of a Butyrophilin Ligand NA Lentini, X Huang, MA Schladetsch, CHC Hsiao, AJ Wiemer, ... ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY 259, 2020 | | 2020 |
| Phosphonamidate prodrugs of a butyrophilin ligand NA Lentini The University of Iowa, 2020 | | 2020 |
| Nonracemic prodrugs of a butyrophilin ligand N Lentini, C Hsiao, A Wiemer, D Wiemer ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY 257, 2019 | | 2019 |
| Evaluation of Mixed Aryl Phosphoantigen Prodrugs CHC Hsiao, BJ Foust, NA Lentini, NM Harmon, DF Wiemer, AJ Wiemer 22nd International Conference on Phosphorus Chemistry, 2018 | | 2018 |
DAVID F. WIEMERF. Wendell Miller Professor of Chemistry & Professor of PharmacologyVerified email at uiowa.edu
